Background Image
Table of Contents Table of Contents
Previous Page  40 / 68 Next Page
Information
Show Menu
Previous Page 40 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 1, January/February 2015

38

AFRICA

Study of the effect of altitude on the measurement of

glycated haemoglobin using point-of-care instruments

Sandra W Veigne, Eugene Sobngwi, Brice E Nouthe, Joelle Sobngwi-Tambekou, Eric V Balti,

Serge Limen, Mesmin Y Dehayem, Vicky Ama, Jean-Louis Nguewa, Maimouna Ndour-Mbaye,

Alioune Camara, Naby M Balde, Jean-Claude Mbanya

Abstract

We measured the glycated haemoglobin (HbA

1c

) levels of

a total of 24 non-diabetic volunteers and diabetic patients

using a point-of-care (POC) analyser in three Cameroonian

cities at different altitudes. Although 12 to 25% of duplicates

had more than 0.5% (8 mmol/mol) difference across the

sites, HbA

1c

values correlated significantly (

r

=

0.89–0.96).

Further calibration studies against gold-standard measures

are warranted.

Keywords:

glycated haemoglobin, altitude, diabetes

Submitted 7/12/14, accepted 18/12/14

Cardiovasc J Afr

2015;

26

: 38–40

www.cvja.co.za

DOI: 10.5830/CVJA-2014-078

HbA

1c

concentration is used for the appropriate diagnosis and

management of diabetes,

1,2

but the standard way of measurement

requires an expensive and time-consuming ion-exchange, high-

performance liquid chromatography (HPLC) technology. Point-

of-care (POC) instruments represent a cheaper alternative to

determine HbA

1c

levels in five to 10 minutes. They can be

used by non-laboratory staff to tailor a patient’s care and

educational messages to HbA

1c

values and clinical findings in a

one-stop-shop approach.

3,4

Their potential shortcomings include

cases of haemoglobinopathy or some environmentally linked

limitations.

5,6

While operating temperature and humidity are easily

controlled, altitude cannot be standardised for operation. We

investigated the performance of one of the most commonly used

POC HbA

1c

instruments in African clinical settings, situated at

varying altitudes.

Methods

In this cross-sectional study, HbA

1c

concentrations were measured

in three cities of Cameroon in blood samples simultaneously

collected from the same individuals. The study settings were

Douala (13-m altitude), Yaounde (650-m altitude), and Bamenda

(1 600-m altitude).

The study was approved by the National Ethics Committee of

Cameroon. All participants gave their informed consent.

The study participants were 24 volunteers distributed in

four groups: six non-diabetic (healthy) volunteers [no clinical

symptoms, fasting glycaemia

<

1.26 g/dl (6.99 mmol/l) and HbA

1c

levels

<

6.6% (

<

49 mmol/mol)], six patients with diabetes with

HbA

1c

levels

<

6.6% (

<

49 mmol/mol), six patients with HbA

1c

levels at 6.6–8.0% (49–64 mmol/mol) and six patients with HbA

1c

levels

>

8.0% (

>

64 mmol/mol).

All patients had to have had diabetes for at least one year,

with stable treatment and HbA

1c

values over at least three

months preceding the study defined by HbA

1c

variation

<

1%

between two measurements. Exclusion criteria included any

haemoglobinopathy, recent malaria, haematological disorder or

any other acute medical condition in the preceding month, total

haemoglobin level

>

11 g/dl, and creatinine clearance

<

60 ml/min.

National Obesity Center, Yaoundé Central Hospital and

Faculty of Medicine and Biomedical Sciences, University

of Yaoundé 1, Yaoundé, Cameroon

Sandra W Veigne, MD

Eugene Sobngwi, MD, MPhil, PhD,

sobngwieugene@yahoo.fr

Brice E Nouthe, MD

Eric V Balti, MD

Serge Limen, MD

Mesmin Y Dehayem, MD

Vicky Ama, MD

Jean-Louis Nguewa, MD

Jean-Claude Mbanya, MD

Molecular Medicine and Metabolism Laboratories,

Bio-technology Center, University of Yaoundé 1, Yaoundé,

Cameroon

Eugene Sobngwi, MD, MPhil, PhD

Jean-Claude Mbanya, MD

Department of Medicine, McGill University, Montreal,

Quebec, Canada

Brice E Nouthe, MD

Centre of Higher Education in Health Sciences, Catholic

University of Central Africa, Yaoundé, Cameroon

Joelle Sobngwi-Tambekou, MD

Diabetes Research Center, Faculty of Medicine and

Pharmacy, Brussels Free University-VUB, Brussels, Belgium

Eric V Balti, MD

Cheick Anta Diop University, Dakar, Senegal

Maimouna Ndour-Mbaye, MD

University Teaching Hospital of Donka, Conakry, Guinea

Alioune Camara, MD

Naby M Balde, MD

University of Technology, Kingston, Jamaica

Jean-Claude Mbanya, MD